Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
726 Establishing proof of mechanism in patients: preliminary biomarker data of SRK-181 (a latent TGFβ1 inhibitor) from DRAGON Study
Compose a Response to This Article
Other responses
No responses have been published for this article.
